Status:
COMPLETED
Ultrasound (US) Measurement of Sarcopenia in the Elder Subject
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Sarcopenia
Eligibility:
All Genders
75+ years
Phase:
NA
Brief Summary
Sarcopenia is a generalized, progressive and multifactorial muscle impairment, causing multiple pathologies and their consequences such as falls, fractures, dependence, worsening of cognitive disorder...
Eligibility Criteria
Inclusion
- Age 75 or older
- SARC-F \> 4
- Decrease in muscle strength: grip strength \<27 kg for men and \<16 kg for women; and/or Chair stand test \< 15 seconds
- Patient affiliated or beneficiary of a social security plan
- Patient who has signed informed consent beforehand
Exclusion
- Neurocognitive disorder preventing the expression of informed consent
- Lack of a measurement site (muscle resection or amputation)
- Impossibility or contraindication to strict dorsal and/or ventral decubitus
- Any associated neuromuscular pathology that may alter muscle composition and trophicity
- Wearing a pacemaker
- Any state of water inflation or dehydration
- History of surgery on the studied lower limb less than 6 months old
- Patients protected by law under guardianship or under curate, or unable to participate in a clinical study under Article L. 1121-16 of the French Code of Public Health
Key Trial Info
Start Date :
October 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04842773
Start Date
October 26 2021
End Date
August 31 2023
Last Update
November 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Nice
Nice, Provence-Alpes-Côte d'Azur Region, France, 06000